Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity
- PMID: 17190727
- DOI: 10.1080/10641960601096745
Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity
Abstract
Nitric oxide (NO) in the central nervous system inhibits sympathetic nerve activity, thereby decreasing blood pressure. It is unknown, however, whether orally administered antihypertensive treatment alters NO synthase (NOS) expression, particularly in the brain, and how changes in NOS expression affects sympathetic nerve activity. Azelnidipine, a recently developed long-acting dihydropyridine calcium channel blocker, does not cause baroreflex-induced tachycardia. The aim of the present study was to determine whether antihypertensive treatment with azelnidipine alters endothelial NOS (eNOS), neuronal NOS (nNOS), or inducible NOS (iNOS) expression in the brain, and how changes in NOS affect sympathetic nerve activity. Azelnidipine (20 mg/kg/day) or hydralazine (20 mg/kg/day) was orally administered for 30 days in stroke-prone spontaneously hypertensive rats (SHRSP). Blood pressure and heart rate were measured by the tail cuff method. Urinary norepinephrine excretion was measured as a marker of sympathetic nerve activity. Western blot analysis was performed to examine eNOS, nNOS, or iNOS expression levels in the brain (cortex, cerebellum, hypothalamus, and the brain stem), heart, and aorta. The extent of blood pressure reduction was similar between the two groups. Heart rate increased in the hydralazine-treated group but did not change in the azelnidipine-treated group. Urinary norepinephrine excretion was significantly increased only in the hydralazine-treated group. Treatment with azelnidipine significantly increased eNOS expression levels in the brain, heart, and aorta, but did not alter nNOS or iNOS expression levels. Treatment with hydralazine did not change any of the NOS expression levels. These results suggest that antihypertensive treatment with azelnidipine attenuates reflex-induced sympathetic activation and enhances eNOS expression levels in the brain as well as in the heart and aorta.
Similar articles
-
Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.J Cardiovasc Pharmacol. 2008 Dec;52(6):555-60. doi: 10.1097/FJC.0b013e318192690e. J Cardiovasc Pharmacol. 2008. PMID: 19057394
-
Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.Hypertens Res. 2005 Dec;28(12):1017-23. doi: 10.1291/hypres.28.1017. Hypertens Res. 2005. PMID: 16671342
-
Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats.Hypertens Res. 2007 Apr;30(4):359-66. doi: 10.1291/hypres.30.359. Hypertens Res. 2007. PMID: 17541215
-
Effect of overproduction of nitric oxide in the brain stem on the cardiovascular response in conscious rats.J Cardiovasc Pharmacol. 2003 Jan;41 Suppl 1:S119-26. J Cardiovasc Pharmacol. 2003. PMID: 12688408 Review.
-
Control of systemic and pulmonary blood pressure by nitric oxide formed through neuronal nitric oxide synthase.J Hypertens. 2009 Oct;27(10):1929-40. doi: 10.1097/HJH.0b013e32832e8ddf. J Hypertens. 2009. PMID: 19587610 Review.
Cited by
-
L/T-type calcium channel blocker reduces non-Gaussianity of heart rate variability in chronic kidney disease patients under preceding treatment with ARB.J Renin Angiotensin Aldosterone Syst. 2016 Apr 18;17(2):1470320316643905. doi: 10.1177/1470320316643905. Print 2016 Apr-Jun. J Renin Angiotensin Aldosterone Syst. 2016. PMID: 27094219 Free PMC article. Clinical Trial.
-
Polytropic Influence of TRIB3 rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension.Front Pharmacol. 2019 Mar 27;10:236. doi: 10.3389/fphar.2019.00236. eCollection 2019. Front Pharmacol. 2019. PMID: 30971918 Free PMC article.
-
Essential hypertension: an approach to its etiology and neurogenic pathophysiology.Int J Hypertens. 2013;2013:547809. doi: 10.1155/2013/547809. Epub 2013 Dec 9. Int J Hypertens. 2013. PMID: 24386559 Free PMC article. Review.
-
Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes.Drugs Context. 2018 Jan 3;7:212509. doi: 10.7573/dic.212509. eCollection 2018. Drugs Context. 2018. PMID: 29344052 Free PMC article. Review.
-
How mental stress affects endothelial function.Pflugers Arch. 2011 Dec;462(6):779-94. doi: 10.1007/s00424-011-1022-6. Epub 2011 Sep 23. Pflugers Arch. 2011. PMID: 21947555 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources